Policy, Research

Shockwave (SWAV): Volatility Ahead?

John Leppard, VP Senior Healthcare Analyst
09 February 2023

Summary

We give no better than 50% odds to CMS forestalling an implied facility cut of 25%+ for Shockwave’s (SWAV) C2 coronary intravascular lithotripsy (IVL) procedures, once its Transitional Pass-Through (TPT) payment ends next year as part of the agency’s CY24 hospital outpatient/ASC proposed rule due out in early July.


Want to learn more? Download the Report.

Solutions

Public Policy Research
Identify opportunity and risks driven by public policy.
Fundamental Equity Research
Gain a comprehensive view of global themes, industries, and companies.
Forensic Accounting Research
Understand implications of public company financial reporting.